PALISADE BIO, INC.: 10-K filed 2012-03-30
What PALISADE BIO, INC. reported in its annual report filed 2012-03-30 (fiscal FY 2011): 26 published measures, 67 facts as tagged in accession 0001144204-12-018248.
This filing
- Form
- 10-K (annual report)
- Filed
- 2012-03-30
- Fiscal period
- fiscal FY 2011
- Accession
- 0001144204-12-018248 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PALISADE BIO, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 4,086,177 | USD | |
| At 2010-12-31 | 10,591,360 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 2,426,359 | USD | |
| At 2010-12-31 | 2,737,010 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 1,659,818 | USD | |
| At 2010-12-31 | 7,854,350 | USD | |
| At 2009-12-31 | -5,015,456 | USD | |
| At 2008-12-31 | -2,556,546 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 2,352,013 | USD | |
| At 2010-12-31 | 9,261,233 | USD | |
| At 2009-12-31 | 2,309,774 | USD | |
| At 2008-12-31 | 4,903,279 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -12,518,527 | USD | 365 |
| 2010-01-01 to 2010-12-31 | -18,387,300 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -10,364,363 | USD | 365 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -8,096,696 | USD | 365 |
| 2010-01-01 to 2010-12-31 | -9,981,244 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -5,144,820 | USD | 365 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 196,412 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 76,322 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 88,378 | USD | 365 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 390,625 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 733,438 | USD | 365 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 1,668,326 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 17,265,378 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 2,762,099 | USD | 365 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -480,850 | USD | 365 |
| 2010-01-01 to 2010-12-31 | -332,675 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -210,784 | USD | 365 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | -98,472,658 | USD | |
| At 2010-12-31 | -85,954,131 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 292,193 | USD | |
| At 2010-12-31 | 200,084 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 3,333,099 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 5,240,882 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 4,556,916 | USD | 365 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -12,990,470 | USD | 365 |
| 2010-01-01 to 2010-12-31 | -15,184,881 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -10,466,549 | USD | 365 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 3,016,744 | USD | |
| At 2010-12-31 | 9,830,247 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 821 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 2,662 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 776 | USD | 365 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 2,426,359 | USD | |
| At 2010-12-31 | 2,737,010 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 234,375 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 13,381,095 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 15,918,319 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 10,466,549 | USD | 365 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 7,354,857 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 9,163,810 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 5,346,904 | USD | 365 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 48,682,118 | shares | |
| At 2010-12-31 | 46,897,529 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 99,645,655 | USD | |
| At 2010-12-31 | 93,339,506 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 701,846 | USD | |
| At 2010-12-31 | 500,154 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 75,394 | USD | |
| At 2010-12-31 | 60,875 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 5,839,188 | USD | 365 |
| 2010-01-01 to 2010-12-31 | 6,623,758 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 5,030,981 | USD | 365 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 471,943 | USD | 365 |
| 2010-01-01 to 2010-12-31 | -3,202,419 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 102,186 | USD | 365 |
Inspect the source
- Entity
- PALISADE BIO, INC. / CIK 0001357459
- Captured
- 2026-09-20T07:55:46.162Z
- SEC response SHA-256
1d4973c07aed8ad894103731546b55683b331acdd472b37e4b33a98a2f63a74c
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001357459.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))